G13.2 - Systemic atrophy primarily affecting the central nervous system in myxedema
The ICD 10 Code for Systemic atrophy primarily affecting the central nervous system in myxedema is listed as G13.2.
Additional information concerning this code and description can be found below including ICD 9 crosswalks / GEMS, chapter information, and DRGs where available.
| ICD 10 CM Field | Value |
|---|---|
| Diagnosis Code: | G13.2
|
| Description: | Systemic atrophy primarily affecting the central nervous system in myxedema
|
| Diagnostic Related Groups
(MS-DRG v30.0) |
056 - Degenerative Nervous System Disorders W Mcc
057 - Degenerative Nervous System Disorders W/o Mcc |
| Chapter | Diseases of the nervous system (G00-G99) |
| Block | Systemic atrophies primarily affecting the central nervous system (G10-G14) |
| Parent | G13 - Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere |
| ICD-9-CM Diagnosis Codes General Equivalence Mappings (GEMS): | |
| ICD 9 Dx Code: | 331.7 - Cerebral degeneration in diseases classified elsewhere (approximate) |
| ICD-10-CM Siblings (same level / similar specificity) of G13.2: | |
| G13.0 - Paraneoplastic neuromyopathy and neuropathy | |
| G13.1 - Other systemic atrophy primarily affecting central nervous system in neoplastic disease | |
| G13.8 - Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere | |